These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1196 related articles for article (PubMed ID: 18582458)

  • 1. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
    Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the renal renin-angiotensin system and renoprotection by pitavastatin in type1 diabetes.
    Toba H; Mitani T; Takahashi T; Imai N; Serizawa R; Wang J; Kobara M; Nakata T
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1064-70. PubMed ID: 20678154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
    Toba H; Yoshida M; Tojo C; Nakano A; Oshima Y; Kojima Y; Noda K; Wang J; Kobara M; Nakata T
    Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The direct antioxidative and anti-inflammatory effects of peroxisome proliferator-activated receptors ligands are associated with the inhibition of angiotensin converting enzyme expression in streptozotocin-induced diabetic rat aorta.
    Toba H; Miki S; Shimizu T; Yoshimura A; Inoue R; Sawai N; Tsukamoto R; Murakami M; Morita Y; Nakayama Y; Kobara M; Nakata T
    Eur J Pharmacol; 2006 Nov; 549(1-3):124-32. PubMed ID: 16979161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production.
    Toyonaga J; Tsuruya K; Ikeda H; Noguchi H; Yotsueda H; Fujisaki K; Hirakawa M; Taniguchi M; Masutani K; Iida M
    Nephrol Dial Transplant; 2011 Aug; 26(8):2475-84. PubMed ID: 21220752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension-induced renal fibrosis and spironolactone response vary by rat strain and mineralocorticoid receptor gene expression.
    Cavallari LH; Fashingbauer LA; Camp JR; King ST; Geenen DL
    J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):146-53. PubMed ID: 18957385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of spironolactone on glomerular injury in streptozotocin-induced diabetic rats.
    Yuan J; Jia R; Bao Y
    J Renin Angiotensin Aldosterone Syst; 2007 Sep; 8(3):118-26. PubMed ID: 17907099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiproteinuric effects of mineralocorticoid receptor blockade in patients with chronic renal disease.
    Sato A; Hayashi K; Saruta T
    Am J Hypertens; 2005 Jan; 18(1):44-9. PubMed ID: 15691616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy.
    Thallas-Bonke V; Coughlan MT; Bach LA; Cooper ME; Forbes JM
    Am J Nephrol; 2010; 32(1):73-82. PubMed ID: 20551625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
    Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of transforming growth factor-beta1 gene expression by Danggui buxue tang, a traditional Chinese herbal preparation, in retarding the progress of renal damage in streptozotocin-induced diabetic rats.
    Zhang YW; Xie D; Xia B; Zhen RT; Liu IM; Cheng JT
    Horm Metab Res; 2006 Feb; 38(2):82-8. PubMed ID: 16523407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
    Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term mineralocorticoid receptor blockade ameliorates progression of experimental diabetic renal disease.
    Lian M; Hewitson TD; Wigg B; Samuel CS; Chow F; Becker GJ
    Nephrol Dial Transplant; 2012 Mar; 27(3):906-12. PubMed ID: 21908416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mineralocorticoid receptor antagonist spironolactone prevents pig serum-induced hepatic fibrosis in rats.
    Fujisawa G; Muto S; Okada K; Kusano E; Ishibashi S
    Transl Res; 2006 Sep; 148(3):149-56. PubMed ID: 16938653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
    Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
    Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats.
    Fujisawa G; Okada K; Muto S; Fujita N; Itabashi N; Kusano E; Ishibashi S
    Kidney Int; 2004 Oct; 66(4):1493-502. PubMed ID: 15458443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anabolic steroid associated to physical training induces deleterious cardiac effects.
    Do Carmo EC; Fernandes T; Koike D; Da Silva ND; Mattos KC; Rosa KT; Barretti D; Melo SF; Wichi RB; Irigoyen MC; de Oliveira EM
    Med Sci Sports Exerc; 2011 Oct; 43(10):1836-48. PubMed ID: 21407130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of glomerular heparanase expression by aldosterone, angiotensin II and reactive oxygen species.
    van den Hoven MJ; Waanders F; Rops AL; Kramer AB; van Goor H; Berden JH; Navis G; van der Vlag J
    Nephrol Dial Transplant; 2009 Sep; 24(9):2637-45. PubMed ID: 19429930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAAS inhibitors directly reduce diabetes-induced renal fibrosis via growth factor inhibition.
    Koszegi S; Molnar A; Lenart L; Hodrea J; Balogh DB; Lakat T; Szkibinszkij E; Hosszu A; Sparding N; Genovese F; Wagner L; Vannay A; Szabo AJ; Fekete A
    J Physiol; 2019 Jan; 597(1):193-209. PubMed ID: 30324679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.